Skip to content
Royal Today Media

Zimbabwe Turns Down ‘Unbalanced’ American Health Aid Deal Over Data Apprehensions

Medical aid illustration
The proposed US financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for sensitive biological samples.

This rejection was revealed after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".

A government spokesperson has since clarified that the US was demanding access to biological samples for research and profit while refused to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for continued dialogue to reach a agreement acceptable to all parties so the country's vital HIV programme can be sustained.

Broader Context

Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US after concerns were raised about the safety of citizens' medical information.

Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.

Based on reports, 16 African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.

Details of the Declined Deal

This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to share its biological resources and data indefinitely, without any equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that shared data," he stated.

"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a future pandemic arise."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending systems already set up via the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This framework is intended to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued dialogue with our US partners on how future collaboration could be arranged in a manner that respects the independence and interests of both nations."

Medical Community Reaction

Medical experts said it understood the government's concerns, but suggested that negotiations must proceed since much of the nation's HIV programmes depended on international support.

"If technical issues arise, such as those relating to information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group added.

The halted deal underscores the complex debate between receiving crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.

By

Mr. Chase Erickson

A seasoned journalist with a passion for uncovering stories that matter, Evelyn brings over a decade of experience in UK media and digital storytelling.

Royal Today Media

Type to search articles.